The global industrial enzyme market has reached a scale of several billion US dollars. Applications in diagnostics and pharmaceuticals have shown strong growth in recent years, with certain segments recording double-digit annual growth for several consecutive years. However, in practical production, one issue remains particularly prominent: enzyme molecules are prone to inactivation under high temperatures, extreme pH conditions, or mechanical shear forces. This lack of stability means that many enzyme formulations still require additional process control and optimization when transitioning from laboratory research to large-scale industrial production.

Creative Enzymes has recently updated and upgraded its enzyme stabilization and formulation service offerings. According to the company, the platform integrates several widely used stabilization approaches, including enzyme immobilization, chemical modification, and protein engineering, while also incorporating formulation optimization using additive or polymer-based systems. These methods are typically combined depending on specific application scenarios to address stability challenges during storage, transportation, and actual reaction processes.

Industry observers generally note that, compared with single-formulation adjustments, this more systematic approach may help improve the usability and consistency of enzymes under complex conditions.

Enzyme inactivation can result from structural changes or molecular clustering. The platform addresses these issues using several physical and chemical approaches. The process uses an immobilization method to bind enzyme molecules to solid carriers. This improves the tolerance of the enzyme to changing temperatures. Furthermore, if covalent bonds are formed between enzyme molecules, the tendency of the molecules to unfold is reduced. The goal is to improve enzyme robustness in industrial products without compromising catalytic efficiency.

Enzyme stabilization in lab conditions is only the beginning of the process, according to Dr. Charles, Head of Purification Sciences. He stated, "The real commercial value lies in the final product. That means combining stabilization with later-stage processes, such as formulation." The company claims to provide stabilization services for enzymes in quantities ranging from milligrams to tons, with specific stabilization protocols designed for either research or industry. Currently, the integrated service has been used by certain probiotic manufacturers, in-vitro diagnostic reagent companies, and industrial enzyme users. All have validated its effectiveness on real production lines.

The company understands that claims are not sufficient for the assessment of how stable the enzyme is. Therefore, Creative Enzymes has developed a rapid and systematic enzyme stability testing platform, including aging studies and defining an enzyme's heat resistance and activity. The company claims that its case studies give sufficient data to show that a lipase for industrial reactors retained over 90% of its activity after 12 months, and that the half-life of a chemically modified protease was extended from 48 hours to over 3 months. The company states that these results are well-documented and greatly outperform the industry average.

Creative Enzymes is a biotechnology company providing enzymes, probiotics, natural extracts, and related technical services for research and industrial applications. Its service offerings include enzyme stabilization, formulation development, and stability testing, serving a customer base spanning pharmaceuticals, food, agriculture, and bioenergy.